MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Nov 14, 11:21 AM (EDT)
Price
$2.02
Change
-$0.02 (-0.98%)
Capitalization
139.71M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STIM with price predictions
Nov 13, 2025

Momentum Indicator for STIM turns negative, indicating new downward trend

STIM saw its Momentum Indicator move below the 0 level on November 04, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for STIM turned negative on October 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

STIM moved below its 50-day moving average on October 29, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

STIM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 245 cases where STIM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.107) is normal, around the industry mean (63.280). P/E Ratio (0.000) is within average values for comparable stocks, (36.719). STIM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.683). STIM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.912) is also within normal values, averaging (55.025).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STIM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 29.08% to -9 cents per share on March 10

Neuronetics STIM Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Est.
$-0.13
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -12 cents, meeting the estimate of -12 cents. With 143.66K shares outstanding, the current market capitalization sits at 139.71M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNARF12.390.20
+1.64%
Morguard North American Residential Real Estate Investment Trust
PMDRF0.09N/A
N/A
BRASNOVA ENERGY MATLS INC.
SGSOY11.54-0.02
-0.17%
SGS SA
HEGIY17.97-0.27
-1.49%
Hengan International Group Co., Ltd.
GTMAY0.75-0.25
-25.00%
Grupo TMM S.A.B.

STIM and Stocks

Correlation & Price change

A.I.dvisor tells us that STIM and BWAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and BWAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-1.82%
BWAY - STIM
32%
Poorly correlated
+3.95%
DIZTF - STIM
31%
Poorly correlated
N/A
DCTH - STIM
29%
Poorly correlated
-0.35%
TMCI - STIM
28%
Poorly correlated
-1.04%
ARAY - STIM
28%
Poorly correlated
+0.85%
More

Groups containing STIM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-1.82%
Medical/Nursing Services
industry (215 stocks)
25%
Poorly correlated
-2.32%
Health Services
industry (422 stocks)
1%
Poorly correlated
-2.10%